MedTrace Logo

The Effect of Ondansetron on Cardiac Output in Elective Cesarean Deliveries

NCT01841606 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2018-05-11

Study results available
· View outcomes & findings →

Summary

Ondansetron is a medication routinely given to mothers having cesarean deliveries to help prevent and treat nausea and vomiting. The investigators are studying the hemodynamic effects of prophylactic ondansetron on parturients undergoing elective cesarean deliveries under spinal anesthesia.

Conditions

  • Cardiac Output

Interventions

DRUG

Ondansetron

4mg of IV ondansetron

OTHER

Normal saline

10mL of IV normal saline

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Vit Gunka, MD FRCPC · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01841606 on ClinicalTrials.gov